Physicochemical and biological characterization of GNR-087, a Tocilizumab biosimilar
{{output}}
GNR-087 developed by IBC Generium, Russia is a biosimilar candidate to Tocilizumab reference product. A comprehensive analytical assessment of the structural and functional similarity of GNR-087 and Tocilizumab reference product is one of the steps of the step... ...
